Wegovy 1.0 mg: what happens at this point in the dose schedule?

Why does the schedule pass through 1.0 mg rather than jumping straight to the maintenance dose?

Semaglutide is a GLP-1 receptor agonist. It slows how quickly the stomach empties, which is part of how it reduces appetite, but that same slowing is also why nausea and digestive discomfort are the most commonly reported side effects, particularly early on. The NHS patient information on semaglutide explains that the titration schedule (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and then 2.4 mg) exists specifically so the body can adjust at each level before the dose increases again.

At 1.0 mg, many people find the nausea they may have experienced in the first few weeks has settled. Appetite suppression is more consistent than it was at 0.5 mg for most patients, though individual responses vary. If you want a closer look at what this particular step involves, the Wegovy 1 mg page covers what to expect at this stage of the schedule. The 1.0 mg pen is the same pre-filled device as every other Wegovy strength, a once-weekly subcutaneous injection into the abdomen, thigh or upper arm, rotated between sites. If you are curious about how the earlier steps compare, the 0.5 mg stage covers what most people experience in weeks five to eight.

Can a prescriber keep you at 1.0 mg for longer than four weeks?

Yes, and this is not unusual. The standard schedule moves through each level in approximately four-week steps, but that is a guide rather than a fixed rule. A prescriber may decide a slower increase is right, perhaps because earlier side effects were significant, or because the patient's circumstances make a steadier progression sensible. The Wegovy SmPC, available on the Electronic Medicines Compendium, notes that the titration rate can be adjusted for tolerability.

What a prescriber will not do is leave someone at 1.0 mg if the aim is to reach the licensed maintenance dose. The 1.0 mg step is a waypoint. It gets you to a therapeutic dose that is effective for weight management; it is not that dose itself. If you want to understand how the strengths relate to one another, the Wegovy mg guide explains how each dose fits into the overall treatment journey. The broader Wegovy dose schedule maps the full pathway through to the 2.4 mg maintenance pen and, where clinically appropriate, the newer 7.2 mg option approved by the MHRA in early 2026. A note on cost context: if you are thinking about what private Wegovy treatment involves financially at each stage, the weight-loss treatment overview sets out what is typically included.

What side effects are most common at the 1.0 mg level, and when should you act?

The side-effect picture at 1.0 mg broadly mirrors earlier stages, though some people find the step brings a short-lived return of nausea as the body adjusts. The most frequently reported effects across the semaglutide trial programme were gastrointestinal: nausea, loose stools, constipation, indigestion and burping. For most participants these were mild to moderate and tended to ease within one to two weeks.

A small number of people experience more pronounced symptoms. Severe, persistent stomach pain that extends to the back, with or without vomiting, is a reason to seek urgent medical attention because it can be a sign of pancreatitis, a rare but serious side effect the MHRA highlighted in a drug safety update in January 2026. Dehydration from prolonged vomiting or diarrhoea is also worth taking seriously. If you are unsure whether what you are experiencing needs medical attention, calling 111 or speaking to a GP is the right step, not adjusting your own dose.

The Wegovy overview page covers the full side-effect profile in more detail. For questions specific to your treatment, the aftercare team at nume is available seven days a week, get in touch any time.

What arrives when you order Wegovy through a regulated UK pharmacy?

It is worth knowing what the physical product looks like, particularly if you are new to injectable treatments. Each Wegovy pen is pre-filled, pre-set to the correct dose, and has a covered needle mechanism, you do not need to draw up any liquid or handle a separate needle. When dispatched through a GPhC-registered pharmacy like ours, the pen arrives via DPD in plain, unbranded packaging, with tracking sent to your phone so you know exactly when to expect it.

Storage matters: Wegovy pens should be kept in the fridge at 2 to 8 degrees Celsius. There is a limited window during which the pen can be kept at room temperature before use, but the exact period is specified in the Patient Information Leaflet that comes with your pen, always follow that rather than a general figure online.

If you are considering starting Wegovy, the first step is a clinical consultation. Our prescribers (led by our clinical team) review every application personally before anything is issued. You can read more about what the process involves on the guide to where Wegovy can be obtained in the UK, or head straight to our FAQs if you have a specific question about the service.